Sara Rosenbaum (Chair)
Those who specialize in civil rights have been extremely active around passage and implementation of the ACA because it is self-evident that gains for low-income Americans are, in effect, gains for minority Americans in the US. The ACA, of course, makes a seminal contribution to the problem. The Kaiser Family Foundation just published a study showing the disproportionately large impact of the Act on minority Americans, who are much more likely to be uninsured. To the extent that a central purpose of the Act is to create more equal access, its benefits for minority Americans should be seen as one of the greatest civil rights achievements of our time.
Marcella Alsan, MD, MPH, PhD, is a professor of public policy at Harvard Kennedy School. Dr. Alsan received a BA from Harvard University, a master’s in public health from Harvard School of Public Health, an MD from Loyola University and a PhD in Economics from Harvard University. Dr. Alsan trained at Brigham and Women’s Hospital Hiatt Global Health Equity Residency Fellowship, then combined the PhD with an Infectious Disease Fellowship at Massachusetts General Hospital. Prior to returning to Harvard, she was on faculty at Stanford. She is an applied microeconomist studying health inequality. Some recent papers include “Does Diversity Matter for Health: Experimental Evidence from Oakland” and “Tuskegee and the Health of Black Men,” published in the American Economic Review and the Quarterly Journal of Economics, respectively. These papers have been cited in the New York Times and other major media outlets and findings have been presented to the Association of American Medical Colleges and the Centers for Disease Control and Prevention. Dr. Alsan is currently on the Board of Editors for Science Magazine, Co-editor of the Journal of Health Economics and Co-chair of the Health Care Delivery Initiative of Abdul Latif Jameel Poverty Action Lab based out of MIT. She is a co-recipient of the 2019 Arrow Award for Best Paper in Health Economics.
Zachary W. Carter
Zachary W. Carter retired in 2019 as Corporation Counsel of New York City. During his tenure, he resolved long-standing litigation, ushering in a new era of equity and justice for the city. Memorable settlements range from the overuse of stop and frisk and the Central Park Five case to excessive uses of force at Rikers Island and the underrepresentation of racial minorities in the ranks of the Fire Department of the City of New York. Previously, Mr. Carter was the head of the New York Trial Department and Co-Chair of the White Collar Crime and Civil Fraud practice at Dorsey & Whitney LLP. He practiced in the areas of white collar criminal defense, complex civil litigation, representation of government-regulated industries, representation of government contractors, corporate governance and compliance, and securities class action litigation. Prior to joining Dorsey & Whitney as a partner, Mr. Carter served as the United States Attorney for the Eastern District of New York. Mr. Carter is a member of the Board of Trustees at New York University School of Law. He has been a member of the Board of Directors of Marsh & McLennan Companies, Cablevision, Hale House, Vera Institute of Justice and Prisoners’ Legal Services.
I realized that I wanted a career that would allow me to help people directly, one-on-one, and see the results of my work. That’s why I decided to pursue a career in medicine. I was in private practice as a physician for 20 years, and I enjoyed meeting a wide variety of people every day, getting to know them and helping them. In that sense, medicine is a very rewarding career. At the same time, I had always known that I wanted to pursue intellectual and policy-related work. After 11 or 12 years in medical practice, I cut my work hours from about 65 to 50 hours a week in order to pursue a Master of Public Health degree. Later I received a PhD from the University of California, Berkeley. My experience as a family physician has influenced my research interests a great deal; that’s obvious from the work I’ve done. Having worked as a physician in the community, I have a sense of the way physicians in this country think about issues.
I’m actually one of the few people who think that employer-sponsored coverage is a strong institution and is not likely to disappear any time soon. It offers many advantages even compared with the health insurance exchanges. There is a good reason, especially in very large companies, to retain employer-sponsored health insurance, but I can see it fading out among the smaller firms over time. Employers are pretty innovative, so we will continue to see changes in the way employer-sponsored coverage operates. We don’t entirely know what those trends are going to be yet and I am not enthusiastic about predicting, so we’ll see.
Christopher F. Koller
As a society, we need to consider the role of price transparency as opposed to charge transparency, and the role of public organizations, trusted community-wide efforts, national nonprofit resources like FAIR Health and private initiatives in making that price information more readily accessible to different stakeholders—consumers, providers, researchers and others.
James W. Lytle
James W. Lytle is a senior counsel at Manatt, Phelps & Phillips LLP, where he operates out of the firm’s Albany and Boston offices and participates in the firm’s New York State government, regulatory and policy practice and as a member of Manatt Health, the firm’s healthcare law and consulting practice. He represents a broad array of clients, especially in the healthcare and higher education arenas, before the legislature and the executive branch and has represented clients in administrative hearings and throughout all levels of the state court system, including the state’s highest court. Mr. Lytle is the former Chair of the Health Law Section of the New York State Bar Association and served as Assistant Counsel for Health and Human Services to Governor Mario M. Cuomo from 1983 to 1986. He is currently an adjunct professor of Health Law at New York University School of Law and has also been an adjunct professor at the State University of New York (SUNY) at Albany School of Public Health, New York Medical College School of Health Sciences and Practices and SUNY College of Optometry. He has been consistently recognized by Chambers USA and by The Best Lawyers in America, which named him the 2017 Lawyer of the Year in Albany for healthcare and governmental relations and Albany Lawyer of the Year for government relations again in 2019. A graduate of Princeton University and Harvard Law School, Mr. Lytle is currently a fellow at the Advanced Leadership Initiative at Harvard University.
Lynn B. Nicholas
I grew up in Knoxville, Tennessee, and had an uncle who worked as a medic in the labs at Oak Ridge National Laboratory. That’s where they previously secretly created the fuel for the atomic bomb during World War II. Although my uncle couldn’t share much about his work, whatever little he could share absolutely fascinated me. I had always wanted to know how things worked biologically and was intrigued by all aspects of nature. In fact, my career paper in junior high school was entitled “The Doctor’s Doctor: The Role of the Pathologist”.
As I progressed through undergrad education, I thought about nursing but I couldn’t see myself working with patients and preferred to work with test tubes, microscopes and analytical equipment. After a stint of running the laboratories in a hospital, I advanced into healthcare administration and policy work. I had quickly learned that I preferred working with people over pathogens, but I never lost my interest in all things clinical.
Fortuitous events, more than anything else, led me to become involved in healthcare. I completed my actuarial exams in South Africa where, at the time, there was not much actuarial involvement in healthcare. I was working for one of the large South African life insurance companies that also owned what was called a “medical aid society”—essentially a not-for-profit health plan. South Africa is very similar to the United States in terms of having a predominantly private health insurance market. My company and other life insurance companies became more involved in healthcare as a result of changes in regulation. I continued in the healthcare sector because it was, to me, much more dynamic than the more traditional actuarial fields of life insurance or pensions. It seemed to be more directly relevant to individuals; there were multiple stakeholders and numerous issues to address.
A few years later, when I moved to the United Kingdom (UK), some of the actuarial consulting firms were starting private health insurance practices. Given my background, I was hired by Milliman’s affiliate in the UK as it was starting to develop a healthcare actuarial practice. While in the UK, I met my wife, who is American, and we later moved to the United States. Health actuarial work in the United States is incredibly diverse and over the years I have been fortunate to be involved in what has always seemed to be an important national discussion.
James Roosevelt, Jr.
As a volunteer hospital board member, healthcare lawyer and health plan executive, I have had the opportunity to work on all sides of the healthcare world. That experience has taught me the importance of good, impartial data. My community activism and government service have shown me how access to information improves people's lives. The chance to work with an organization that focuses on accuracy, value and fairness in healthcare payment is a rare coalescing of personal background and professional goals. I look forward to supporting that work and raising its profile.